STLLF - Stallergenes Greer plc

Other OTC - Other OTC Delayed Price. Currency in USD
0.00 (0.00%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close29.62
Bid0.00 x 0
Ask0.00 x 0
Day's Range29.62 - 29.62
52 Week Range29.62 - 37.25
Avg. Volume0
Market CapN/A
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters

    French healthcare group Stallergenes to be bought out by Bertarelli vehicle

    French healthcare group Stallergenes has agreed to a 730 million euro (£630.88 million) takeover by the Waypoint/Ares Life Sciences vehicle of Swiss billionaire Ernesto Bertarelli, and subsequent de-listing, the companies said on Thursday. The takeover marks the latest example of merger-and-acquisition activity in the global healthcare industry, with Pfizer this week buying a stake in French gene therapy firm Vivet while earlier this year Roche bought Spark Therapeutics for $4.3 billion. Waypoint, which already owns around 83 percent of Stallergenes, will offer 37 euros in cash, representing a 42.9 percent premium to Stallergenes' closing price of 25.90 euros on March 20.

  • Estimating The Fair Value Of Stallergenes Greer plc (EPA:STAGR)
    Simply Wall St.

    Estimating The Fair Value Of Stallergenes Greer plc (EPA:STAGR)

    Does the share price for Stallergenes Greer plc (EPA:STAGR) reflect it’s really worth? Today, I will calculate the stock’s intrinsic value by taking the foreast future cash flows of theRead More...

  • We're sorry this is all we were able to find about this topic.